Clinical Trial Update: Effect of Early Oral Triple Viable Bifidobacterium Intestinal Flora in Preterm [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial evaluating early oral administration of a triple viable Bifidobacterium intestinal flora in preterm infants has completed, with the stu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Disorder of Stomach Function and Feeding Problems in Newborn
• Feeding and Eating Disorders of Childhood

Drugs mentioned

• Triple Viable Bifidobacterium Intestinal Flora (Bifidobacterium probiotic formulation)

Snippet

Sponsor: Wang Hua | Conditions: Disorder of Stomach Function and Feeding Problems in Newborn, Feeding and Eating Disorders of Childhood | Phase 4 | Status: COMPLETED